ABSTRACT
A disfunção da articulação temporomandibular é uma doença que afeta o osso, a cartilagem e os tecidos musculoesqueléticos associados, caracterizada pela presença de dor facial e articular, limitação de abertura de boca, travamento e ruídos articulares. O objetivo deste trabalho prospectivo, simples-cego, randomizado foi avaliar a melhora de abertura interincisal e dor articular em 28 pacientes. Neste ensaio clínico os pacientes foram divididos em 3 grupos aleatórios de acordo com a técnica de tratamento que foi utilizada. Os pacientes do grupo 1 foram submetidos a artrocentese isolada e os do grupo 2 e 3 a artrocentese seguida de infiltração de ácido hialurônico ou plasma rico em plaquetas (PRP), respectivamente. Os pacientes foram reavaliados para avaliação de abertura interincisal dor articular e qualidade de vida após 2 semanas, 1, 3 e 6 meses. Nenhuma diferença estatisticamente significativa foi observada entre os grupos para qualquer uma das alterações nos parâmetros EAVN ou medidas MAI(p< 0.05). Para a variável qualidade de vida os resultados foram clinicamente significativos em todos os grupos avaliados (p>0.05). Os três grupos avaliados apresentaram melhoras clínicas significativas(AU)
Temporomandibular joint dysfunction is a disease that affects bone, cartilage and associated musculoskeletal tissues, characterized by the presence of facial and joint pain, limited mouth opening, locking and joint noises. The aim of this prospective, single-blind, randomized study was to evaluate the improvement of interincisal opening and joint pain using a visual analog scale in 28 patients. In this clinical trial, patients were divided into 3 random groups according to the treatment technique that will be used. Patients in group 1 underwent arthrocentesis alone and those in groups 2 and 3 underwent arthrocentesis followed by infiltration of hyaluronic acid or platelet-rich plasma (PRP), respectively. Patients were reassessed for assessment of interincisal opening joint pain and quality of life after 2 weeks, 1, 3, and 6 months. No statistically significant differences were observed between the groups for any of the changes in VAS parameters or MAI measurements (p< 0.05). For the quality of life variable, the results were clinically significant in all groups evaluated (p>0.05). The three groups evaluated showed significant clinical improvements(AU)
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Temporomandibular Joint Dysfunction Syndrome , PainABSTRACT
Introduction: The Sturge-Weber Syndrome, also known as encephalotrigeminal angiomatosis, is a rare vascular neurocutaneous alteration. The main clinical features of this syndrome are facial vascular cutaneous naevus, usually unilateral, which often follows the outline distribution of trigeminal nerve. Objective: To report a clinical case of Sturge-Weber Syndrome in a 29-yeral-old male patient who presented oral manifestations related to the syndrome. Case report and conclusion: The patient reported that he had presented a cutaneous vascular nevus on the face during childhood as well as epileptic crisis episodes. However, he had no ophthalmic alterations. Sturge-Weber syndrome is a systemic condition commonly affecting oral cavity through vascular lesions, therefore, dentists' knowledge is extremely important to provide an adequate dental treatment without complications.